Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
- Starting date:
- April 12, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-69658
Last updated: 2019-04-16
Summary
-
Product:
Hydromorph Contin - Controlled Release Capsule 24 mg
Reason
Affected lots may contain hydromorphone levels outside of the labelled claim.
Depth of distribution
Wholesalers, Retailers, Healthcare Establishments
Affected products
Hydromorph Contin - Controlled Release Capsule 24 mg
DIN, NPN, DIN-HIM
DIN 02125382
Dosage form
Capsule
Strength
Hydromorphone hydrochloride 24 mg
Lot or serial number
135272, 135529, 136263, 137226, 137482, 137934, 138568, 138820, 139454, 139842
Companies
- Recalling Firm
-
Purdue Pharma
575 Granite Court
Pickering
L1W 3W8
Ontario
CANADA
- Marketing Authorization Holder
-
Purdue Pharma
575 Granite Court
Pickering
L1W 3W8
Ontario
CANADA